Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 6
2006 5
2007 3
2008 6
2009 3
2010 11
2011 8
2012 9
2013 15
2014 18
2015 22
2016 15
2017 18
2018 21
2019 23
2020 32
2021 18
2022 20
2023 23
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

246 results

Results by year

Filters applied: . Clear all
Page 1
Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma.
Rask Kragh Jørgensen R, Bergström F, Eloranta S, Tang Severinsen M, Bjøro Smeland K, Fosså A, Haaber Christensen J, Hutchings M, Bo Dahl-Sørensen R, Kamper P, Glimelius I, E Smedby K, K Parsons S, Mae Rodday A, J Maurer M, M Evens A, C El-Galaly T, Hjort Jakobsen L. Rask Kragh Jørgensen R, et al. Among authors: e smedby k. JCO Clin Cancer Inform. 2024 Apr;8:e2300255. doi: 10.1200/CCI.23.00255. JCO Clin Cancer Inform. 2024. PMID: 38608215 Free article.
Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis.
Ren W, Wan H, Own SA, Berglund M, Wang X, Yang M, Li X, Liu D, Ye X, Sonnevi K, Enblad G, Amini RM, Sander B, Wu K, Zhang H, Wahlin BE, Smedby KE, Pan-Hammarström Q. Ren W, et al. Among authors: smedby ke. Leukemia. 2024 Mar;38(3):610-620. doi: 10.1038/s41375-023-02120-7. Epub 2023 Dec 29. Leukemia. 2024. PMID: 38158444 Free PMC article.
Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy.
Harrysson S, Eloranta S, Ekberg S, Enblad G, Andersson PO, Sonnevi K, Ljungqvist M, Sander B, Jerkeman M, Smedby KE. Harrysson S, et al. Among authors: smedby ke. Leuk Lymphoma. 2024 Apr;65(4):534-537. doi: 10.1080/10428194.2023.2296361. Epub 2023 Dec 22. Leuk Lymphoma. 2024. PMID: 38134325 No abstract available.
Secondary malignancies among mantle cell lymphoma patients.
Abalo KD, Smedby KE, Ekberg S, Eloranta S, Pahnke S, Albertsson-Lindblad A, Jerkeman M, Glimelius I. Abalo KD, et al. Among authors: smedby ke. Eur J Cancer. 2023 Dec;195:113403. doi: 10.1016/j.ejca.2023.113403. Epub 2023 Oct 29. Eur J Cancer. 2023. PMID: 37952281 Free article.
Prevalence and predictors for fertility-related distress among 1010 young adults 1.5 years following cancer diagnosis - results from the population-based Fex-Can Cohort study.
Rodriguez-Wallberg KA, Ahlgren J, Smedby KE, Gorman JR, Hellman K, Henriksson R, Ståhl O, Wettergren L, Lampic C. Rodriguez-Wallberg KA, et al. Among authors: smedby ke. Acta Oncol. 2023 Dec;62(12):1599-1606. doi: 10.1080/0284186X.2023.2272291. Epub 2023 Nov 25. Acta Oncol. 2023. PMID: 37909865
High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma.
Lewis KL, Jakobsen LH, Villa D, Smedby KE, Savage KJ, Eyre TA, Cwynarski K, Bishton MJ, Fox CP, Hawkes EA, Maurer MJ, El-Galaly TC, Cheah CY; International CNS Prophylaxis Study Group. Lewis KL, et al. Among authors: smedby ke. J Clin Oncol. 2023 Dec 10;41(35):5376-5387. doi: 10.1200/JCO.23.00365. Epub 2023 Oct 5. J Clin Oncol. 2023. PMID: 37797284
246 results